These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

923 related items for PubMed ID: 17845912

  • 1. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M, Spetea M, Friedmann T, Riba P, Király K, Schmidhammer H, Furst S.
    Brain Res Bull; 2007 Oct 19; 74(5):369-75. PubMed ID: 17845912
    [Abstract] [Full Text] [Related]

  • 2. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN, Walker EA.
    J Pharmacol Exp Ther; 2003 Jan 19; 304(1):301-9. PubMed ID: 12490605
    [Abstract] [Full Text] [Related]

  • 3. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I, Spetea M, Guo Y, Schütz J, Windisch P, Schmidhammer H.
    J Pharmacol Exp Ther; 2006 Apr 19; 317(1):220-7. PubMed ID: 16339394
    [Abstract] [Full Text] [Related]

  • 4. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
    Al-Khrasani M, Lackó E, Riba P, Király K, Sobor M, Timár J, Mousa S, Schäfer M, Fürst S.
    Brain Res Bull; 2012 Feb 10; 87(2-3):238-43. PubMed ID: 22079588
    [Abstract] [Full Text] [Related]

  • 5. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 10; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 6. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S, Riba P, Friedmann T, Tímar J, Al-Khrasani M, Obara I, Makuch W, Spetea M, Schütz J, Przewlocki R, Przewlocka B, Schmidhammer H.
    J Pharmacol Exp Ther; 2005 Feb 10; 312(2):609-18. PubMed ID: 15383636
    [Abstract] [Full Text] [Related]

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 10; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 8. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK, Király KP, Lenkey N, Lackó E, Al-Khrasani M, Friedmann T, Timár J, Gyarmati S, Tóth G, Fürst S, Riba P.
    Brain Res Bull; 2013 Jan 10; 90():66-71. PubMed ID: 22995282
    [Abstract] [Full Text] [Related]

  • 9. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2003 Jul 10; 306(1):394-400. PubMed ID: 12721333
    [Abstract] [Full Text] [Related]

  • 10. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A, Baiula M, Gentilucci L, Tolomelli A, De Marco R, Spampinato S.
    Peptides; 2010 Nov 10; 31(11):2135-40. PubMed ID: 20713109
    [Abstract] [Full Text] [Related]

  • 11. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P, Friedmann T, Király KP, Al-Khrasani M, Sobor M, Asim MF, Spetea M, Schmidhammer H, Furst S.
    Brain Res Bull; 2010 Jan 15; 81(1):178-84. PubMed ID: 19800397
    [Abstract] [Full Text] [Related]

  • 12. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M, Boda K, Gintzler AR.
    J Pharmacol Exp Ther; 2004 Jul 15; 310(1):256-62. PubMed ID: 14996951
    [Abstract] [Full Text] [Related]

  • 13. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
    Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1535-42. PubMed ID: 8531126
    [Abstract] [Full Text] [Related]

  • 14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 15; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 15. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 May 15; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
    Watanabe H, Nakayama D, Yuhki M, Sawai T, Sakurada W, Katsuyama S, Hayashi T, Watanabe C, Mizoguchi H, Fujimura T, Sakurada T, Sakurada S.
    Peptides; 2006 Apr 15; 27(4):760-8. PubMed ID: 16226344
    [Abstract] [Full Text] [Related]

  • 17. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM.
    J Pharmacol Exp Ther; 2002 Sep 15; 302(3):1146-50. PubMed ID: 12183674
    [Abstract] [Full Text] [Related]

  • 18. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, Przewlocka B.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):60-7. PubMed ID: 17204264
    [Abstract] [Full Text] [Related]

  • 19. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M, de la Torre-Madrid E, Gaitán G, Sánchez-Blázquez P, Garzón J.
    Cell Signal; 2007 Dec 08; 19(12):2558-71. PubMed ID: 17825524
    [Abstract] [Full Text] [Related]

  • 20. Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats.
    Obara I, Przewlocki R, Przewlocka B.
    Neurosci Lett; 2004 Apr 22; 360(1-2):85-9. PubMed ID: 15082185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.